4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-16-121929
Director bought 45,000 shares at an average $1.53 ($68,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sigal Charles Elliott Director | 2016-05-16 | Purchase | +15,000 | $1.50 | $22,500 | 269,100 | I |
| Sigal Charles Elliott Director | 2016-05-17 | Purchase | +15,000 | $1.53 | $22,950 | 284,100 | I |
| Sigal Charles Elliott Director | 2016-05-18 | Purchase | +15,000 | $1.55 | $23,250 | 299,100 | I |
| Open-market purchases · 45,000 sh · avg $1.53 · $68,700 | |||||||
Loading xslF345X03/a4.xml…